|
|
|
ExCeL London, London
18th & 19th November 2013
Oxford Global is proud to present the Single Cell Analysis Congress taking place on 18-19 November 2013 in London. New technology has made single cell analysis possible. The exciting opportunities offered by this growing field of research look to change the face of personalised medicine and dramatically improve our understanding of a wide variety of diseases. Over two days, 400 senior level experts from internationally renowned academic institutions and leading pharmaceutical organisations will be bought together to create an interactive platform for high-level scientific and business discussion on the future of single cell analysis. Our panel of experts will look at breakthrough technologies including amplification and isolation methods, as well as innovative solutions for integrating proteomics and metabolomics information. The event will also explore the application of single genomics in a range of therapeutic areas and corresponding implications in clinical and diagnostic development. Do not miss out on case studies on the latest developments in single cell sequencing, transcriptome analysis and quantitative imaging. The congress will feature stimulating presentation, world class key note addresses, ample networking opportunities and thought-provoking panel discussions, making this meeting a must attend for anyone working in the field. The event will be co-located with the prestigious 5th Annual Next Generation Sequencing Congress, a high level meeting featuring case study presentations from clinical research institutions, pharmaceutical companies and food/nutrition companies that explore the key strategies in using next generation sequencing technologies & platforms.
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
Invited Speakers:
|
|
Yuriy Alekseyev Director, Microarray Resource, Research Assistant Professor, Department of Pathology and Laboratory Medicine, BUSM
Wilhelm Ansorge Professor, EPFL
Julie Audet Associate Professor, University of Toronto
David Bensimon Research Director, The ABCD Lab, Ecole Normale Superieure
Michael Bevan Head of the Cell and Developmental Biology, JIC
Valesca Boisguérin Head of Medical Genomics, TRON (Translational Oncology), Mainz, Germany
Joseph Boland Director of R&D, National Cancer Institute, USA
James Bradford Senior Bioinformatics Scientist, Oncology iMED R&D, AstraZeneca, UK
Gareth Butland Staff Scientist, Life Sciences Division, Lawrence Berkeley National Laboratory, USA
Oscar Ces Co-Chair of the Institute of Chemical Biology, Imperial College London, Director of the Institute of Chemical Biology Centre for Doctoral Training
|
|
|
|
|
|
Deadline for Abstracts:
|
|
TBC
|
|
|
|
|
|
Registration:
|
|
For more information please visit http://www.singlecell-congress.com/download-agenda-marketing
|
|
|
|
|
|
|
|